The Endoprosthesis Market Size was valued at USD 10.13 billion in 2023 and is expected to reach USD 23.70 billion by 2031 and grow at a CAGR of 11.21% over the forecast period 2024-2031.
Endoprosthesis is a treatment that involves the use of an implant to replace a joint in the body that has lost its ability to function due to injury or illness. Common indications for the use of an endoprosthesis include degenerative joint disease, fractures, and malignancies. The increasing prevalence of osteoarthritis among the older population, technological improvements in endoprosthesis devices permitting efficient treatment, and increased population awareness are driving the worldwide endoprosthesis market. However, the undesirable effects and high costs associated with endoprosthesis are anticipated to limit market expansion.
Get more information on Endoprosthesis Market - Request Sample Report
Improvements in endoprosthesis design and materials are leading to better treatment outcomes
Endoprosthesis technological improvements enable better treatment, and increased awareness for prosthetics in orthopaedic injuries are fueling the growth of the end prosthesis market.
The prevalence of knee and hip osteoarthritis is rapidly growing as the ageing population grows
Limited Infrastructure & Affordability
Developing countries often lack the necessary healthcare infrastructure and financial resources to support widespread endoprosthesis procedures. This limits market growth in these regions.
Reimbursement policies, particularly in low- and middle-income countries, may not adequately cover the cost of endoprosthesis surgeries.
Growing Patient & Doctor Awareness
As patients and healthcare professionals become more aware of the latest advancements in endoprosthesis technology, the market has the potential for long-term growth. This can lead to a higher acceptance rate of these procedures.
Increased Innovation
Performance of Indigenous Products
In some regions, locally-produced endoprosthesis products may not yet match the performance and reliability of established brands. This can make patients hesitant to choose them.
Limited Reimbursement
The Russia Ukraine war looms large over the endoprosthesis market due to the disruptions in global supply chains due to the conflict threaten shortages of materials and finished products, impacting not just Europe but also regions reliant on imports from these areas. Furthermore, the war's economic strain may lead to healthcare budget cuts, limiting hospital purchases of endoprostheses and potentially restricting patient access due to reduced insurance coverage. Additionally, the focus shift towards addressing war-related medical needs in Ukraine and surrounding countries could cause delays in elective surgeries like endoprosthesis replacements. Sanctions on Russia further complicate the situation, potentially hindering their ability to import these medical devices and prompting some Western manufacturers to halt exports in protest.
An economic slowdown dampens the outlook for the endoprosthesis market which lessened healthcare budgets, both public and private, could limit hospital purchases of implants and patient access to procedures. This financial strain might also lead individuals to delay elective surgeries due to out-of-pocket costs or reduced insurance coverage. Furthermore, economic uncertainty could discourage investment in research and development, hindering the introduction of new and improved technologies.
However, there are potential opportunities which mainly focus on cost-effectiveness during an economic downturn could drive the adoption of more affordable endoprosthesis options. Additionally, advancements in technology aimed at improving the efficiency and affordability of these procedures could pave the way for long-term market growth. The overall impact will depend on the severity and duration of the slowdown, but the industry has the potential to adapt by focusing on cost-effective solutions and technological advancements.
Knee
Hip
Shoulder
Elbow
Finger/Hand
Ankle/Foot
The endoprosthesis market is dominated by knee replacements, driven by two key factors such as an aging population and rising obesity rates. This factor is likely to continue due to the high prevalence of knee osteoarthritis, particularly among those aged 55-64 according to the Arthritis Foundation in the US. This segment holds the largest market share due to the increasing demand for knee replacement surgeries.
Primary
Partial
Revision Knee Replacement
Tumor
Custom Made
The endoprosthesis market for knees can be segmented into several categories based on the procedure type: primary, partial, revision, tumor, and custom-made implants. Notably, revision knee replacements currently generate the highest revenue within this market segment. Knee replacement surgery itself involves resurfacing damaged knee joints with implants made from metal, high-density polyethylene, or ceramic. During the procedure, surgeons remove the worn-out cartilage and bone from the shinbone, thighbone, and kneecap before placing the artificial joint. This surgery is popular due to the significant improvement in patients' ability to perform daily activities after recovery.
Primary
Partial
Revision Hip Replacement
Tumor
Custom Made
Revision hip replacements currently lead in revenue generation this dominance is likely fueled by the rising prevalence of hip osteoarthritis in an aging population, alongside growing patient awareness of prosthetic solutions for orthopedic issues.
Primary
Revision Shoulder Replacement
Tumor
Custom Made
Revision surgeries currently hold the top revenue spot within this segment. This factor might be linked to the shoulder's complex range of motion, making it susceptible to wear and tear.
Total Elbow
Radial Head Replacement
Tumor
Custom Made
Radial head replacements currently capture the highest revenue within this segment. While elbow replacements are less frequent than knee or hip surgeries, they offer similar benefits in pain reduction and regaining daily function.
In 2023, North America had the greatest market share. The endoprosthesis market in North America is being driven by the region's increased use of technically advanced healthcare items as well as an increase in arthritis instances.
South America has shown significant growth in the endoprosthesis market, with a 14.6% market share in 2023. Endoprosthesis procedures are performed in a variety of medical settings throughout South America, including government-controlled laboratories. Patients who are financially independent frequently choose private laboratory care. Brazil is one of the leading countries in the South American endoprosthesis market, with the greatest market share.
Asia-Pacific is expected to develop at the fastest rate during the projection period of 2023 to 2031, with a CAGR of 12.78%. This is due to factors such as the region's growing older population, an increase in the incidence of osteoarthritis, and increased spending on healthcare infrastructure. Every day, more people become aware of numerous ailments and the importance of receiving high-quality care. In China, around 50,000 knee and hip arthroplasties are performed each year. This figure is likely to rise significantly in the coming years due to an increase in the incidence of orthopaedic injuries and orthopaedic ailments among the country's elderly population.
Europe has a 24.59 percent market share in 2023 and is predicted to grow at a 12.41% CAGR during the forecast period. The rise in the senior population, higher prevalence of joint problems, and enhanced healthcare infrastructure in the region are all contributing to market expansion.
The Middle East and Africa endoprosthesis market is expanding due to considerable improvements in healthcare infrastructure and the growing presence of important players in the area.
Need any customization research on Endoprosthesis Market - Enquiry Now
REGIONAL COVERAGE:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Major Players are Johnson & JohnsonServices, Inc., CorinLtd, MedactaInternational SA, BraunMelsungenAG, Zimmer Biomet Holdings Inc., Baumer S.A., Stryker, Smith & Nephew, Exactech, Inc., MicroPortOrthopedics,Inc. and Other Players.
RECENT DEVELOPMENTS:
In April 2022, Medacta International SA achieved a milestone by performing the first lumbar fusion procedure in the US that combined the M.U.S.T Pedicle Screw System with NextAR Spine. This signifies a significant step forward as it integrates an augmented reality (AR) surgical application (NextAR Spine) with a screw system (M.U.S.T) for intraoperative guidance during spine surgery.
Zimmer Biomet Holdings, a leading medical technology company, secured FDA clearance for their Identity Shoulder System in September 2022. This clearance allows the system to be used for various procedures including revision, anatomic, and reverse shoulder replacements.
Report Attributes | Details |
---|---|
Market Size in 2023 | US$ 10.13 Billion |
Market Size by 2031 | US$ 23.70 Billion |
CAGR | CAGR of 11.21% From 2024 to 2031 |
Base Year | 2023 |
Forecast Period | 2024-2031 |
Historical Data | 2020-2022 |
Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
Key Segments | By Product (Knee, Hip, Shoulder, Elbow, Finger/Hand, Ankle/Foot), By Knee (Primary, Partial, Revision Knee Replacement, Tumor, Custom Made), By Hip (Primary, Partial, Revision Hip Replacement, Tumor, Custom Made), By Shoulder (Primary, Revision Shoulder Replacement, Tumor, Custom Made), By Elbow (Total Elbow, Radial Head Replacement, Tumor, Custom Made) |
Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
Company Profiles | Johnson & JohnsonServices, Inc., CorinLtd, MedactaInternational SA, BraunMelsungenAG, Zimmer Biomet Holdings Inc., Baumer S.A., Stryker, Smith & Nephew, Exactech, Inc., MicroPortOrthopedics,Inc. |
Key Drivers |
|
RESTRAINTS |
|
Ans: The Endoprosthesis market is grown at a CAGR of 11.21% From 2024 to 2031.
Ans: The Endoprosthesis market is expected to reach USD 23.70 billion by 2031.
Ans: An endoprosthesis is a treatment that involves the use of an implant to replace a joint in the body that has lost its ability to function due to injury or illness.
Ans: The forecast period of the Endoprosthesis Market is 2024-2031.
Rising awareness of modern technologies among patients and healthcare professionals would give a long-term potential for the endoprosthesis industry to flourish.
An increase in the number of product launches, mergers and acquisitions, and expansion
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Impact Analysis
5.1 Impact of Russia-Ukraine Crisis
5.2 Impact of Economic Slowdown on Major Countries
5.2.1 Introduction
5.2.2 United States
5.2.3 Canada
5.2.4 Germany
5.2.5 France
5.2.6 UK
5.2.7 China
5.2.8 Japan
5.2.9 South Korea
5.2.10 India
6. Value Chain Analysis
7. Porter’s 5 Forces Model
8. Pest Analysis
9. Endoprosthesis Market Segmentation, By Product
9.1 Introduction
9.2 Trend Analysis
9.3 Knee
9.4 Hip
9.5 Shoulder
9.6 Elbow
9.7 Finger/Hand
9.8 Ankle/Foot
10. Endoprosthesis Market Segmentation, By Knee
10.1 Introduction
10.2 Trend Analysis
10.3 Primary
10.4 Partial
10.5 Revision Knee Replacement
10.6 Tumor
10.7 Custom Made
11. Endoprosthesis Market Segmentation, By Hip
11.1 Introduction
11.2 Trend Analysis
11.3 Primary
11.4 Partial
11.5 Revision Hip Replacement
11.6 Tumor
11.7 Custom Made
12. Endoprosthesis Market Segmentation, By Shoulder
12.1 Introduction
12.2 Trend Analysis
12.3 Primary
12.4 Revision Shoulder Replacement
12.5 Tumor
12.6 Custom Made
13. Endoprosthesis Market Segmentation, By Elbow
13.1 Introduction
13.2 Trend Analysis
13.3 Total Elbow
13.4 Radial Head Replacement
13.5 Tumor
13.6 Custom Made
14. Regional Analysis
14.1 Introduction
14.2 North America
14.2.1 Trend Analysis
14.2.2 North America Endoprosthesis Market By Country
14.2.3 North America Endoprosthesis Market By Product
14.2.4 North America Endoprosthesis Market By Knee
14.2.5 North America Endoprosthesis Market By Hip
14.2.6 North America Endoprosthesis Market, By Shoulder
14.2.7 North America Endoprosthesis Market, By Elbow
14.2.8 USA
14.2.8.1 USA Endoprosthesis Market By Product
14.2.8.2 USA Endoprosthesis Market By Knee
14.2.8.3 USA Endoprosthesis Market By Hip
14.2.8.4 USA Endoprosthesis Market, By Shoulder
14.2.8.5 USA Endoprosthesis Market, By Elbow
14.2.9 Canada
14.2.9.1 Canada Endoprosthesis Market By Product
14.2.9.2 Canada Endoprosthesis Market By Knee
14.2.9.3 Canada Endoprosthesis Market By Hip
14.2.9.4 Canada Endoprosthesis Market, By Shoulder
14.2.9.5 Canada Endoprosthesis Market, By Elbow
14.2.10 Mexico
14.2.10.1 Mexico Endoprosthesis Market By Product
14.2.10.2 Mexico Endoprosthesis Market By Knee
14.2.10.3 Mexico Endoprosthesis Market By Hip
14.2.10.4 Mexico Endoprosthesis Market, By Shoulder
14.2.10.5 Mexico Endoprosthesis Market, By Elbow
14.3 Europe
14.3.1 Trend Analysis
14.3.2 Eastern Europe
14.3.2.1 Eastern Europe Endoprosthesis Market By Country
14.3.2.2 Eastern Europe Endoprosthesis Market By Product
14.3.2.3 Eastern Europe Endoprosthesis Market By Knee
14.3.2.4 Eastern Europe Endoprosthesis Market By Hip
14.3.2.5 Eastern Europe Endoprosthesis Market By Shoulder
14.3.2.6 Eastern Europe Endoprosthesis Market, By Elbow
14.3.2.7 Poland
14.3.2.7.1 Poland Endoprosthesis Market By Product
14.3.2.7.2 Poland Endoprosthesis Market By Knee
14.3.2.7.3 Poland Endoprosthesis Market By Hip
14.3.2.7.4 Poland Endoprosthesis Market By Shoulder
14.3.2.7.5 Poland Endoprosthesis Market, By Elbow
14.3.2.8 Romania
14.3.2.8.1 Romania Endoprosthesis Market By Product
14.3.2.8.2 Romania Endoprosthesis Market By Knee
14.3.2.8.3 Romania Endoprosthesis Market By Hip
14.3.2.8.4 Romania Endoprosthesis Market By Shoulder
14.3.2.8.5 Romania Endoprosthesis Market, By Elbow
14.3.2.9 Hungary
14.3.2.9.1 Hungary Endoprosthesis Market By Product
14.3.2.9.2 Hungary Endoprosthesis Market By Knee
14.3.2.9.3 Hungary Endoprosthesis Market By Hip
14.3.2.9.4 Hungary Endoprosthesis Market By Shoulder
14.3.2.9.5 Hungary Endoprosthesis Market, By Elbow
14.3.2.10 Turkey
14.3.2.10.1 Turkey Endoprosthesis Market By Product
14.3.2.10.2 Turkey Endoprosthesis Market By Knee
14.3.2.10.3 Turkey Endoprosthesis Market By Hip
14.3.2.10.4 Turkey Endoprosthesis Market By Shoulder
14.3.2.10.5 Turkey Endoprosthesis Market, By Elbow
14.3.2.11 Rest of Eastern Europe
14.3.2.11.1 Rest of Eastern Europe Endoprosthesis Market By Product
14.3.2.11.2 Rest of Eastern Europe Endoprosthesis Market By Knee
14.3.2.11.3 Rest of Eastern Europe Endoprosthesis Market By Hip
14.3.2.11.4 Rest of Eastern Europe Endoprosthesis Market By Shoulder
14.3.2.11.5 Rest of Eastern Europe Endoprosthesis Market, By Elbow
14.3.3 Western Europe
14.3.3.1 Western Europe Endoprosthesis Market By Country
14.3.3.2 Western Europe Endoprosthesis Market By Product
14.3.3.3 Western Europe Endoprosthesis Market By Knee
14.3.3.4 Western Europe Endoprosthesis Market By Hip
14.3.3.5 Western Europe Endoprosthesis Market By Shoulder
14.3.3.6 Western Europe Endoprosthesis Market, By Elbow
14.3.3.7 Germany
14.3.3.7.1 Germany Endoprosthesis Market By Product
14.3.3.7.2 Germany Endoprosthesis Market By Knee
14.3.3.7.3 Germany Endoprosthesis Market By Hip
14.3.3.7.4 Germany Endoprosthesis Market By Shoulder
14.3.3.7.5 Germany Endoprosthesis Market, By Elbow
14.3.3.8 France
14.3.3.8.1 France Endoprosthesis Market By Product
14.3.3.8.2 France Endoprosthesis Market By Knee
14.3.3.8.3 France Endoprosthesis Market By Hip
14.3.3.8.4 France Endoprosthesis Market By Shoulder
14.3.3.8.5 France Endoprosthesis Market, By Elbow
14.3.3.9 UK
14.3.3.9.1 UK Endoprosthesis Market By Product
14.3.3.9.2 UK Endoprosthesis Market By Knee
14.3.3.9.3 UK Endoprosthesis Market By Hip
14.3.3.9.4 UK Endoprosthesis Market By Shoulder
14.3.3.9.5 UK Endoprosthesis Market, By Elbow
14.3.3.10 Italy
14.3.3.10.1 Italy Endoprosthesis Market By Product
14.3.3.10.2 Italy Endoprosthesis Market By Knee
14.3.3.10.3 Italy Endoprosthesis Market By Hip
14.3.3.10.4 Italy Endoprosthesis Market By Shoulder
14.3.3.10.5 Italy Endoprosthesis Market, By Elbow
14.3.3.11 Spain
14.3.3.11.1 Spain Endoprosthesis Market By Product
14.3.3.11.2 Spain Endoprosthesis Market By Knee
14.3.3.11.3 Spain Endoprosthesis Market By Hip
14.3.3.11.4 Spain Endoprosthesis Market By Shoulder
14.3.3.11.5 Spain Endoprosthesis Market, By Elbow
14.3.3.12 Netherlands
14.3.3.12.1 Netherlands Endoprosthesis Market By Product
14.3.3.12.2 Netherlands Endoprosthesis Market By Knee
14.3.3.12.3 Netherlands Endoprosthesis Market By Hip
14.3.3.12.4 Netherlands Endoprosthesis Market By Shoulder
14.3.3.12.5 Netherlands Endoprosthesis Market, By Elbow
14.3.3.13 Switzerland
14.3.3.13.1 Switzerland Endoprosthesis Market By Product
14.3.3.13.2 Switzerland Endoprosthesis Market By Knee
14.3.3.13.3 Switzerland Endoprosthesis Market By Hip
14.3.3.13.4 Switzerland Endoprosthesis Market By Shoulder
14.3.3.13.5 Switzerland Endoprosthesis Market, By Elbow
14.3.3.14 Austria
14.3.3.14.1 Austria Endoprosthesis Market By Product
14.3.3.14.2 Austria Endoprosthesis Market By Knee
14.3.3.14.3 Austria Endoprosthesis Market By Hip
14.3.3.14.4 Austria Endoprosthesis Market By Shoulder
14.3.3.14.5 Austria Endoprosthesis Market, By Elbow
14.3.3.15 Rest of Western Europe
14.3.3.15.1 Rest of Western Europe Endoprosthesis Market By Product
14.3.3.15.2 Rest of Western Europe Endoprosthesis Market By Knee
14.3.3.15.3 Rest of Western Europe Endoprosthesis Market By Hip
14.3.3.15.4 Rest of Western Europe Endoprosthesis Market By Shoulder
14.3.3.15.5 Rest of Western Europe Endoprosthesis Market, By Elbow
14.4 Asia-Pacific
14.4.1 Trend Analysis
14.4.2 Asia-Pacific Endoprosthesis Market By country
14.4.3 Asia-Pacific Endoprosthesis Market By Product
14.4.4 Asia-Pacific Endoprosthesis Market By Knee
14.4.5 Asia-Pacific Endoprosthesis Market By Hip
14.4.6 Asia-Pacific Endoprosthesis Market By Shoulder
14.4.7 Asia-Pacific Endoprosthesis Market, By Elbow
14.4.8 China
14.4.8.1 China Endoprosthesis Market By Product
14.4.8.2 China Endoprosthesis Market By Knee
14.4.8.3 China Endoprosthesis Market By Hip
14.4.8.4 China Endoprosthesis Market By Shoulder
14.4.8.5 China Endoprosthesis Market, By Elbow
14.4.9 India
14.4.9.1 India Endoprosthesis Market By Product
14.4.9.2 India Endoprosthesis Market By Knee
14.4.9.3 India Endoprosthesis Market By Hip
14.4.9.4 India Endoprosthesis Market By Shoulder
14.4.9.5 India Endoprosthesis Market, By Elbow
14.4.10 Japan
14.4.10.1 Japan Endoprosthesis Market By Product
14.4.10.2 Japan Endoprosthesis Market By Knee
14.4.10.3 Japan Endoprosthesis Market By Hip
14.4.10.4 Japan Endoprosthesis Market By Shoulder
14.4.10.5 Japan Endoprosthesis Market, By Elbow
14.4.11 South Korea
14.4.11.1 South Korea Endoprosthesis Market By Product
14.4.11.2 South Korea Endoprosthesis Market By Knee
14.4.11.3 South Korea Endoprosthesis Market By Hip
14.4.11.4 South Korea Endoprosthesis Market By Shoulder
14.4.11.5 South Korea Endoprosthesis Market, By Elbow
14.4.12 Vietnam
14.4.12.1 Vietnam Endoprosthesis Market By Product
14.4.12.2 Vietnam Endoprosthesis Market By Knee
14.4.12.3 Vietnam Endoprosthesis Market By Hip
14.4.12.4 Vietnam Endoprosthesis Market By Shoulder
14.4.12.5 Vietnam Endoprosthesis Market, By Elbow
14.4.13 Singapore
14.4.13.1 Singapore Endoprosthesis Market By Product
14.4.13.2 Singapore Endoprosthesis Market By Knee
14.4.13.3 Singapore Endoprosthesis Market By Hip
14.4.13.4 Singapore Endoprosthesis Market By Shoulder
14.4.13.5 Singapore Endoprosthesis Market, By Elbow
14.4.14 Australia
14.4.14.1 Australia Endoprosthesis Market By Product
14.4.14.2 Australia Endoprosthesis Market By Knee
14.4.14.3 Australia Endoprosthesis Market By Hip
14.4.14.4 Australia Endoprosthesis Market By Shoulder
14.4.14.5 Australia Endoprosthesis Market, By Elbow
14.4.15 Rest of Asia-Pacific
14.4.15.1 Rest of Asia-Pacific Endoprosthesis Market By Product
14.4.15.2 Rest of Asia-Pacific Endoprosthesis Market By Knee
14.4.15.3 Rest of Asia-Pacific Endoprosthesis Market By Hip
14.4.15.4 Rest of Asia-Pacific Endoprosthesis Market By Shoulder
14.4.15.5 Rest of Asia-Pacific Endoprosthesis Market, By Elbow
14.5 Middle East & Africa
14.5.1 Trend Analysis
14.5.2 Middle East
14.5.2.1 Middle East Endoprosthesis Market By Country
14.5.2.2 Middle East Endoprosthesis Market By Product
14.5.2.3 Middle East Endoprosthesis Market By Knee
14.5.2.4 Middle East Endoprosthesis Market By Hip
14.5.2.5 Middle East Endoprosthesis Market By Shoulder
14.5.2.6 Middle East Endoprosthesis Market, By Elbow
14.5.2.7 UAE
14.5.2.7.1 UAE Endoprosthesis Market By Product
14.5.2.7.2 UAE Endoprosthesis Market By Knee
14.5.2.7.3 UAE Endoprosthesis Market By Hip
14.5.2.7.4 UAE Endoprosthesis Market By Shoulder
14.5.2.7.5 UAE Endoprosthesis Market, By Elbow
14.5.2.8 Egypt
14.5.2.8.1 Egypt Endoprosthesis Market By Product
14.5.2.8.2 Egypt Endoprosthesis Market By Knee
14.5.2.8.3 Egypt Endoprosthesis Market By Hip
14.5.2.8.4 Egypt Endoprosthesis Market By Shoulder
14.5.2.8.5 Egypt Endoprosthesis Market, By Elbow
14.5.2.9 Saudi Arabia
14.5.2.9.1 Saudi Arabia Endoprosthesis Market By Product
14.5.2.9.2 Saudi Arabia Endoprosthesis Market By Knee
14.5.2.9.3 Saudi Arabia Endoprosthesis Market By Hip
14.5.2.9.4 Saudi Arabia Endoprosthesis Market By Shoulder
14.5.2.9.5 Saudi Arabia Endoprosthesis Market, By Elbow
14.5.2.10 Qatar
14.5.2.10.1 Qatar Endoprosthesis Market By Product
14.5.2.10.2 Qatar Endoprosthesis Market By Knee
14.5.2.10.3 Qatar Endoprosthesis Market By Hip
14.5.2.10.4 Qatar Endoprosthesis Market By Shoulder
14.5.2.10.5 Qatar Endoprosthesis Market, By Elbow
14.5.2.11 Rest of Middle East
14.5.2.11.1 Rest of Middle East Endoprosthesis Market By Product
14.5.2.11.2 Rest of Middle East Endoprosthesis Market By Knee
14.5.2.11.3 Rest of Middle East Endoprosthesis Market By Hip
14.5.2.11.4 Rest of Middle East Endoprosthesis Market By Shoulder
14.5.2.11.5 Rest of Middle East Endoprosthesis Market, By Elbow
14.5.3 Africa
14.5.3.1 Africa Endoprosthesis Market By Country
14.5.3.2 Africa Endoprosthesis Market By Product
14.5.3.3 Africa Endoprosthesis Market By Knee
14.5.3.4 Africa Endoprosthesis Market By Hip
14.5.3.5 Africa Endoprosthesis Market By Shoulder
14.5.3.6 Africa Endoprosthesis Market, By Elbow
14.5.3.7 Nigeria
14.5.3.7.1 Nigeria Endoprosthesis Market By Product
14.5.3.7.2 Nigeria Endoprosthesis Market By Knee
14.5.3.7.3 Nigeria Endoprosthesis Market By Hip
14.5.3.7.4 Nigeria Endoprosthesis Market By Shoulder
14.5.3.7.5 Nigeria Endoprosthesis Market, By Elbow
14.5.3.8 South Africa
14.5.3.8.1 South Africa Endoprosthesis Market By Product
14.5.3.8.2 South Africa Endoprosthesis Market By Knee
14.5.3.8.3 South Africa Endoprosthesis Market By Hip
14.5.3.8.4 South Africa Endoprosthesis Market By Shoulder
14.5.3.8.5 South Africa Endoprosthesis Market, By Elbow
14.5.3.9 Rest of Africa
14.5.3.9.1 Rest of Africa Endoprosthesis Market By Product
14.5.3.9.2 Rest of Africa Endoprosthesis Market By Knee
14.5.3.9.3 Rest of Africa Endoprosthesis Market By Hip
14.5.3.9.4 Rest of Africa Endoprosthesis Market By Shoulder
14.5.3.9.5 Rest of Africa Endoprosthesis Market, By Elbow
14.6 Latin America
14.6.1 Trend Analysis
14.6.2 Latin America Endoprosthesis Market By country
14.6.3 Latin America Endoprosthesis Market By Product
14.6.4 Latin America Endoprosthesis Market By Knee
14.6.5 Latin America Endoprosthesis Market By Hip
14.6.6 Latin America Endoprosthesis Market By Shoulder
14.6.7 Latin America Endoprosthesis Market, By Elbow
14.6.8 Brazil
14.6.8.1 Brazil Endoprosthesis Market By Product
14.6.8.2 Brazil Endoprosthesis Market By Knee
14.6.8.3 Brazil Endoprosthesis Market By Hip
14.6.8.4 Brazil Endoprosthesis Market By Shoulder
14.6.8.5 Brazil Endoprosthesis Market, By Elbow
14.6.9 Argentina
14.6.9.1 Argentina Endoprosthesis Market By Product
14.6.9.2 Argentina Endoprosthesis Market By Knee
14.6.9.3 Argentina Endoprosthesis Market By Hip
14.6.9.4 Argentina Endoprosthesis Market By Shoulder
14.6.9.5 Argentina Endoprosthesis Market, By Elbow
14.6.10 Colombia
14.6.10.1 Colombia Endoprosthesis Market By Product
14.6.10.2 Colombia Endoprosthesis Market By Knee
14.6.10.3 Colombia Endoprosthesis Market By Hip
14.6.10.4 Colombia Endoprosthesis Market By Shoulder
14.6.10.5 Colombia Endoprosthesis Market, By Elbow
14.6.11 Rest of Latin America
14.6.11.1 Rest of Latin America Endoprosthesis Market By Product
14.6.11.2 Rest of Latin America Endoprosthesis Market By Knee
14.6.11.3 Rest of Latin America Endoprosthesis Market By Hip
14.6.11.4 Rest of Latin America Endoprosthesis Market By Shoulder
14.6.11.5 Rest of Latin America Endoprosthesis Market, By Elbow
15. Company Profiles
15.1 Johnson & JohnsonServices, Inc.
15.1.1 Company Overview
15.1.2 Financial
15.1.3 Products/ Services Offered
15.1.4 SWOT Analysis
15.1.5 The SNS View
15.2 CorinLtd
15.2.1 Company Overview
15.2.2 Financial
15.2.3 Products/ Services Offered
15.2.4 SWOT Analysis
15.2.5 The SNS View
15.3 MedactaInternational SA,
15.3.1 Company Overview
15.3.2 Financial
15.3.3 Products/ Services Offered
15.3.4 SWOT Analysis
15.3.5 The SNS View
15.4 BraunMelsungenAG
15.4.1 Company Overview
15.4.2 Financial
15.4.3 Products/ Services Offered
15.4.4 SWOT Analysis
15.4.5 The SNS View
15.5 Zimmer Biomet Holdings Inc.
15.5.1 Company Overview
15.5.2 Financial
15.5.3 Products/ Services Offered
15.5.4 SWOT Analysis
15.5.5 The SNS View
15.6 Baumer S.A.
15.6.1 Company Overview
15.6.2 Financial
15.6.3 Products/ Services Offered
15.6.4 SWOT Analysis
15.6.5 The SNS View
15.7 Smith & Nephew
15.7.1 Company Overview
15.7.2 Financial
15.7.3 Products/ Services Offered
15.7.4 SWOT Analysis
15.7.5 The SNS View
15.8 Stryker
15.8.1 Company Overview
15.8.2 Financial
15.8.3 Products/ Services Offered
15.8.4 SWOT Analysis
15.8.5 The SNS View
15.9 Exactech, Inc.
15.9.1 Company Overview
15.9.2 Financial
15.9.3 Products/ Services Offered
15.9.4 SWOT Analysis
15.9.5 The SNS View
15.10 MicroPortOrthopedics,Inc.
15.10.1 Company Overview
15.10.2 Financial
15.10.3 Products/ Services Offered
15.10.4 SWOT Analysis
15.10.5 The SNS View
16. Competitive Landscape
16.1 Competitive Benchmarking
16.2 Market Share Analysis
16.3 Recent Developments
16.3.1 Industry News
16.3.2 Company News
16.3.3 Mergers & Acquisitions
17. Use Case and Best Practices
18. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Prescription Drugs Market size was valued at USD 1162.60 Billion In 2023 & is estimated to reach USD 2173.61 Billion by 2032 and increase at a CAGR of 7.2% between 2024 and 2032.
The Oral Care Market size was valued at USD 37.5 Bn in 2023 and is expected to reach USD 63.47 by Bn by 2031, with a growing CAGR of CAGR of 6.8% over the forecast period 2024-2031.
The Pharmacovigilance and Drug Safety Software Market Size was valued at USD 6.83 billion in 2022, and is expected to reach USD 14.86 billion by 2030, and grow at a CAGR of 10.2% over the forecast period 2023-2030.
Antipsychotic Drugs Market was valued at USD 16.61 billion in 2023 and is expected to reach USD 29.23 billion by 2032, growing at a CAGR of 6.53% from 2024-2032.
The Image-guided Biopsy Market size was valued at USD 2390.85 million in 2023 and is expected to grow to USD 3669.20 million by 2031 and grow at a CAGR of 5.50% over the forecast period of 2024-2031.
The Care Management Solutions Market Size was valued at USD 13.04 billion in 2023 and is expected to reach USD 38.31 billion by 2031, and grow at a CAGR of 14.42% over the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone